125P De-escalation of breast cancer surgery after neoadjuvant systemic therapy in cCR/pCR patients confirmed by vacuum-assisted biopsy (VAB) and SLNB: A first report of the prospective non-randomized trial results

P Krivorotko,V Mortada,L Gigolaeva,K Nikolaev,V Smirnova,V Kushnarev,E Busko,A Artemyeva,A Emelyanov,T Tabagua ,E Zhiltsova ,S Novikov ,P Krzhivitskiy ,R Pesotsky ,Z Bryantseva ,S Yerechshenko ,A Belyaev ,A Komyahov ,T Semiglazova ,V Semiglazov

doi:10.1016/j.annonc.2022.03.142

125P De-escalation of breast cancer surgery after neoadjuvant systemic therapy in cCR/pCR patients confirmed by vacuum-assisted biopsy (VAB) and SLNB: A first report of the prospective non-randomized trial results

P Krivorotko, V Mortada + Show 18 more

https://doi.org/10.1016/j.annonc.2022.03.142

Copy DOI

Journal: Annals of Oncology	Publication Date: May 1, 2022
Citations: 1

Affiliation: National Medical Research Center of Cardiology

#Refusal Of Surgery #Vacuum-assisted Biopsy + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

The aim of the study is to prove efficacy and safety of refusal of traditional breast surgery in BC patients who develop cCR after NAT. Refusal of surgery was offered to exceptional responders after vacuum-assisted tumour bed biopsy and sentinel lymph node biopsy confirmed absence of residual disease (pCR).

Full Text